Cutera Obtains Japanese Regulatory Clearance for enlighten™

enlighten is the first and only picosecond laser granted clearance 
by Japan’s Ministry of Health, Labour and Welfare

BRISBANE, Calif., March 31, 2016 -- Cutera, Inc. (NASDAQ:CUTR) (“Cutera” or the “Company”), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, announced today that Japan’s medical device regulatory authority, the Ministry of Health, Labour and Welfare, granted regulatory clearance for its enlighten^TM picosecond laser platform.

“We are pleased to be first to market in Japan with a clearance for our enlighten platform for the treatment of benign pigmented lesions, which is the most popular application for enlighten in Asia. As we look forward with our plans for this enabling-technology platform, obtaining additional international clearances for enlighten is one of the key components of our international strategy. As such, the Japanese clearance is the latest addition to our growing list of country-specific approvals,” said Kevin Connors, President and CEO of Cutera, Inc.

About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning Cutera's ability to obtain additional clearances for enlighten, increase revenue, and statements regarding long-term prospects and opportunities in the laser and other energy-based equipment aesthetic market are forward-looking statements within the meaning of the Safe Harbor. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera's actual results to differ materially from the statements contained herein. Potential risks and uncertainties that could affect Cutera's business and cause its financial results to differ materially from those contained in the forward-looking statements include  the Company’s ability to successfully develop and launch new products and applications and market them to both its installed base and new customers; unforeseen events and circumstances relating to the Company’s operations; government regulatory actions; and those other factors described in the section entitled, “Risk Factors” in its most recent Form 10-K as filed with the Securities and Exchange Commission on March  15th, 2016. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

CONTACTS: 

Cutera, Inc.
Ron Santilli
Chief Financial Officer
415-657-5500

Investor Relations 
John Mills
Integrated Corporate Relations, Inc. 	
646-277-1254
[email protected]